FDA NDC Directory · JSON-LD · Markdown

oxaliplatin

NDC 42677-337 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerShandong New Time Pharmaceutical Co., Ltd.
Marketing categoryAbbreviated NDA (generic) · App ANDA219765
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsOXALIPLATIN (5 mg/mL)
Marketing started20260115
Package count1

External sources

Source: openFDA. Public-domain (CC0).